01521nam a2200385Ia 4500001001000000003000700010005001700017006001900034007001500053008004100068020003600109020002700145035002200172035002300194035002500217035002300242035002100265040004100286050002200327245010700349260004900456300004600505490005100551504005100602590014700653650003100800650003000831655002900861700002200890710002800912797002000940830006000960856009601020999001901116EBC427662MiAaPQ20250821104337.0m     o  d |      cr cnu||||||||070415s2008    njuaf   ob    001 0 eng d  a9780470187913q(electronic bk.)  z9780471794417q(print)  a(MiAaPQ)EBC427662  a(Au-PeEL)EBL427662  a(CaPaEBR)ebr10296311  a(CaONFJC)MIL202206  a(OCoLC)476269799  aMiAaPQbengerdaepncMiAaPQdMiAaPQ 4aRM302b.D755 200800aDrug-drug interactions in pharmaceutical developmenth[electronic resource] /cedited by Albert P. Li.  aHoboken, N.J. :bWiley-interscience,cc2008.  axiv, 244 p., [1] p.  :bill. (some col.).1 aWiley series in drug discovery and development  aIncludes bibliographical references and index.  aElectronic reproduction. Ann Arbor, MI : ProQuest, 2018. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. 0aDrug interactions.9192560 0aDrug development.9192561 4aElectronic books.9351421 aLi, A. P.91925622 aProQuest (Firm)91925632 aProQuest (Firm) 0aWiley series in drug discovery and development.919256440uhttps://ebookcentral.proquest.com/lib/kuct-ebooks/detail.action?docID=427662zClick to View  c247851d247851